Healthcare EquitiesNovo Nordisk Stock Up 24.9% in 30 Days as AI Restructuring Sharpens GLP-1 FocusSalvado•Jun 5, 2026
Pharma SectorNovo Nordisk Shares Surge 24.9% After Parkinson's AI Deal and Cell Therapy ExitSalvado•May 13, 2026
